Skip to main content
SpringerLink
Log in

Endothelial dysfunction in human diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

In nondiabetic individuals, a poor response to an endothelium-dependent vasodilator in coronary vessels has been shown to increase the likelihood of a future cardiovascular event. Such prospective data are not as yet available in patients with type 1 or type 2 diabetes. However, consistent with the greatly increased cardiovascular risk in these patients, endothelial dysfunction has been almost universally found to characterize patients with type 2 diabetes particularly. Endothelial dysfunction frequently coexists with features of insulin resistance, such as the presence of small dense low-density lipoprotein (LDL) particles even in nondiabetic individuals. This association is independent of obesity and other causes of endothelial dysfunction, such as LDL cholesterol, hypertension, and smoking.

In patients with type 1 diabetes, endothelial dysfunction has been found in approximately half of the studies. In some but not all studies, endothelial dysfunction has been especially severe in patients with poor glycemic control. Reversal or amelioration of endothelial dysfunction has been documented by many commonly used therapeutic agents such as successful insulin therapy, fibrates, and angiotensin-converting enzyme inhibitors, but also with some but not all agents that act as antioxidants. Long-term studies addressing the prognostic significance of endothelial dysfunction and its reversal are urgently needed to determine whether measurement of endothelial function could be used to identify individuals at risk better than can be done at present using classic risk factor assessment among patients with type 2 diabetes especially.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Haffner SM, Lehto S, Rönnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–234. A landmark study that clearly documents that patients with type 2 diabetes with no previous myocardial infarction have the same risk of death from cardiovascular causes as nondiabetic individuals without a previous myocardial infarction.

    Article  PubMed  CAS  Google Scholar 

  2. Jarrett RJ, Shipley MJ: Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease—putative association via common antecedents; further evidence form the Whitehall Study. Diabetologia 1988, 31: 737–740.

    Article  PubMed  CAS  Google Scholar 

  3. Harrison DG: Endothelial control of vasomotion and nitric oxide production. A potential target for risk factor management. Cardiol Clin 1996, 14:1–15.

    PubMed  CAS  Google Scholar 

  4. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 2000, 87:840–844.

    PubMed  CAS  Google Scholar 

  5. Celermajer DS, Sorensen KE, Gooch VM, et al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340:1111–1115.

    Article  PubMed  CAS  Google Scholar 

  6. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989, 2:997–1000.

    Article  PubMed  CAS  Google Scholar 

  7. Chowienczyk PJ, Cockcroft JR, Ritter JM: Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and metacholine in human forearm vasculature. Br J Pharmacol 1993, 110: 763–768.

    Google Scholar 

  8. Creager MA, Cooke JP, Mendelsohn ME, et al.: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990, 86:228–234.

    PubMed  CAS  Google Scholar 

  9. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM: Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992, 340:1430–1432.

    Article  PubMed  CAS  Google Scholar 

  10. Heitzer T, Just H, Münzel T: Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996, 94:6–9.

    PubMed  CAS  Google Scholar 

  11. Egashira K, Inou T, Hirooka Y, et al.: Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993, 88:77–81.

    PubMed  CAS  Google Scholar 

  12. Gerhard M, Roddy A-M, Creager SJ, Creager MA: Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27:849–853.

    PubMed  CAS  Google Scholar 

  13. Schächinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101: 1899–1906. One of the first studies (another is the study by Suwaidi et al. [14]) to document that coronary vasodilator dysfunction predicts future cardiovascular disease.

    PubMed  Google Scholar 

  14. Suwaidi JA, Hamasaki S, Higano ST, et al.: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101: 948–954. One of the first studies (another is the study by Schächinger et al. [13]) to document that coronary vasodilator dysfunction predicts future cardiovascular disease.

    PubMed  CAS  Google Scholar 

  15. De Vriese AS, Verbeuren TJ, Van de Voorde J, et al.: Endothelial dysfunction in diabetes. Br J Pharmacol 2000, 130:963–974. An excellent review of all-animal studies addressing endothelial dysfunction in diabetes.

    Article  PubMed  Google Scholar 

  16. De Tejada IS, Goldstein I, Azadzoi K, et al.: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989, 320:1025–1030.

    Article  Google Scholar 

  17. Jensen-Urstad KJ, Reichard PG, Rosfors JS, et al.: Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996, 45:1253–1258.

    Article  PubMed  CAS  Google Scholar 

  18. Mäkimattila S, Virkamäki A, Groop P-H, et al.: Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 1996, 94:1276–1282.

    PubMed  Google Scholar 

  19. Mäkimattila S, Luoma JS, Ylä-Herttuala S, et al.: Autoantibodies against oxidized LDL and endothelium-dependent vasodilation in insulin-dependent diabetes mellitus. Atherosclerosis 1999, 147:115–122.

    Article  PubMed  Google Scholar 

  20. Mäkimattila S, Mäntysaari M, Groop P-H, et al.: Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in IDDM. Circulation 1997, 95:618–625.

    PubMed  Google Scholar 

  21. Halkin A, Benjamin N, Doktor HS, et al.: Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci 1991, 81: 223–232.

    PubMed  CAS  Google Scholar 

  22. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992, 90:2548–2554.

    PubMed  CAS  Google Scholar 

  23. Elliott TG, Cockcroft JR, Groop P-H, et al.: Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 1993, 85:687–693.

    PubMed  CAS  Google Scholar 

  24. Johnstone MT, Creager SJ, Scales KM, et al.: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993, 88:2510–2516.

    PubMed  CAS  Google Scholar 

  25. Smits P, Kapma J-A, Jacobs M-C, et al.: Endothelium-dependent vascular relaxation in patients with type 1 diabetes. Diabetes 1993, 42:148–153.

    Article  PubMed  CAS  Google Scholar 

  26. MacAllister RJ, Calver AL, Collier J, et al.: Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci 1995, 89:183–190.

    PubMed  CAS  Google Scholar 

  27. O’Driscoll G, Green D, Rankin J, et al.: Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 1997, 100:678–684.

    PubMed  CAS  Google Scholar 

  28. Timimi FK, Ting HH, Haley EA, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 1998, 31: 552–557.

    Article  PubMed  CAS  Google Scholar 

  29. Huvers FC, De Leeuw PW, Houben AJ, et al.: Endothelium-dependent vasodilation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes 1999, 48:1300–1307.

    Article  PubMed  CAS  Google Scholar 

  30. Zenere BM, Arcaro G, Saggiani F, et al.: Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 1995, 18:975–982.

    Article  PubMed  CAS  Google Scholar 

  31. Clarkson P, Celermajer DS, Donald AE, et al.: Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 1996, 28:573–579.

    Article  PubMed  CAS  Google Scholar 

  32. Lambert J, Aarsen M, Donker AJM, Stehouwer CDA: Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:705–711.

    PubMed  CAS  Google Scholar 

  33. Rajman I, Maxwell S, Cramb R, Kendall M: Particle size: the key to the atherogenic lipoprotein? Q J Med 1994, 87:709–720.

    CAS  Google Scholar 

  34. Enderle MD, Benda N, Schmuelling R-M, et al.: Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 1998, 21: 271–277.

    Article  PubMed  CAS  Google Scholar 

  35. Arcaro G, Zenere BM, Saggiani F, et al.: ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 1999, 22:1536–1542.

    Article  PubMed  CAS  Google Scholar 

  36. Meeking DR, Cummings MH, Thorne S, et al.: Endothelial dysfunction in type 1 diabetic subjects with and without microalbuminuria. Diabet Med 1999, 16:841–847.

    Article  PubMed  CAS  Google Scholar 

  37. Schalkwijk CG, Smulders RA, Lambert J, et al.: ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients. Eur J Clin Invest 2000, 30:853–860.

    Article  PubMed  CAS  Google Scholar 

  38. Du X-L, Edelstein D, Rossetti L, et al.: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and includes plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000, 97:12222–12226.

    Article  PubMed  CAS  Google Scholar 

  39. Nishikawa T, Eldstein D, Brownlee M: The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000, 58:S26-S30.

    Article  Google Scholar 

  40. Skyrme-Jones RA, O’Brien RC, Berry KL, Meredith IT: Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 2000, 36:94–102.

    Article  PubMed  CAS  Google Scholar 

  41. Gazis A, White DJ, Page SR, Cockcroft JR: Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endo-thelial function in type 2 diabetes mellitus. Diabet Med 1999, 16:304–311.

    Article  PubMed  CAS  Google Scholar 

  42. Lonn EM, Yusuf S, Dzavik V, et al.: Effects of ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001, 103: 919–925.

    PubMed  CAS  Google Scholar 

  43. Saydah SH, Loria CM, Eberhart MS, Brancati FL: Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 2001, 24:447–453.

    Article  PubMed  CAS  Google Scholar 

  44. Abe H, Yamada N, Kamata K, et al.: Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 1998, 101: 1784–1788.

    PubMed  CAS  Google Scholar 

  45. Vakkilainen J, Mäkimattila S, Seppälä -LindroosA, et al.: Endothelial dysfunction in men with small LDL particles. Circulation 2000, 102: 716–721.

    PubMed  CAS  Google Scholar 

  46. Vehkavaara S, Seppälä-Lindroos A, Westerbacka J, et al.: In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care 1999, 22:2055–2060.

    Article  PubMed  CAS  Google Scholar 

  47. Balletshofer BM, Rittig K, Enderle MD, et al.: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000, 101: 1780–1784.

    PubMed  CAS  Google Scholar 

  48. McVeigh GE, Brennan GM, Johnston GD, et al.: Impaired endothelium-dependent and independent vasodilatation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992, 35:771–776.

    PubMed  CAS  Google Scholar 

  49. Steinberg HO, Chaker H, Leaming R, et al.: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601–2610.

    PubMed  CAS  Google Scholar 

  50. Ting HH, Timimi FK, Boles KS, et al.: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22–28.

    PubMed  CAS  Google Scholar 

  51. Watts GF, O’Brien SF, Silvester W, Millar JA: Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci 1996, 91: 567–573.

    PubMed  CAS  Google Scholar 

  52. O’Brien SF, Watts GF, Playford DA, et al.: Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes. Diabet Med 1997, 14:974–978.

    Article  PubMed  CAS  Google Scholar 

  53. Williams SB, Cusco JA, Roddy M-A, et al.: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996, 27:567–574.

    Article  PubMed  CAS  Google Scholar 

  54. Avogaro A, Piarulli F, Valerio A, et al.: Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 1997, 46:1040–1046.

    Article  PubMed  CAS  Google Scholar 

  55. Hogikyan RV, Galecki AT, Pitt B, et al.: Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 1998, 83:1946–1952.

    Article  PubMed  CAS  Google Scholar 

  56. Mäkimattila S, Liu M, Vakkilailnen J, et al.: Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999, 22:973–981.

    Article  PubMed  Google Scholar 

  57. Clealand SJ, Petrie JR, Small M, et al.: Insulin action is associated with endothelial function in hypertension and type 2 diabetes. Hypertension 2000, 35:507–511.

    Google Scholar 

  58. Steinberg HO, Paradisi G, Cronin J, et al.: Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000, 101: 2040–2046.

    PubMed  CAS  Google Scholar 

  59. Butler R, Morris AD, Belch JJF, et al.: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35:746–751.

    PubMed  CAS  Google Scholar 

  60. Chowienczyk PJ, Brett SE, Gopaul NK, et al.: Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologia 2000, 43:974–977.

    Article  PubMed  CAS  Google Scholar 

  61. Heitzer T, Krohn K, Albers S, Meinertz T: Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000, 43:1435–1438.

    Article  PubMed  CAS  Google Scholar 

  62. McNeill KL, Fontana L, Russell-Jones DL, et al.: Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation. J Am Coll Cardiol 2000, 35:1622–1627.

    Article  PubMed  CAS  Google Scholar 

  63. Vehkavaara S, Mäkimattila S, Schlenzka A, et al.: Insulin therapy improves endothelial function in type 2 diabetes. Arterioscler Thromb Vasc Biol 2000, 20:545–550.

    PubMed  CAS  Google Scholar 

  64. Goodfellow J, Ramsey MW, Luddington LA, et al.: Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 1996, 312: 744–745.

    PubMed  CAS  Google Scholar 

  65. Huvers FC, Schaper NC, Houben AJ, et al.: Impaired arterial but not venous responsiveness to nitroglycerin in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997, 27:360–365.

    Article  PubMed  CAS  Google Scholar 

  66. Morris SJ, Shore AC, Tooke JE: Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995, 38:1337–1344.

    PubMed  CAS  Google Scholar 

  67. Pitei DL, Watkins PJ, Edmonds ME: NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 1997, 14:284–290.

    Article  PubMed  CAS  Google Scholar 

  68. Tan KCB, Ai VHG, Chow WS, et al.: Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 1999, 84:3212–3216.

    Article  PubMed  CAS  Google Scholar 

  69. Skyrme-Jones RA, O’Brien RC, Luo M, Meredith IT: Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. J Am Coll Cardiol 2000, 35:292–299.

    Article  PubMed  CAS  Google Scholar 

  70. Hamilton CA: Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis. Pharmacol Ther 1997, 74:55–72.

    Article  PubMed  CAS  Google Scholar 

  71. Uusitupa MIJ, Niskanen L, Luoma J, et al.: Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:1236–1242.

    PubMed  CAS  Google Scholar 

  72. Zeng G, Nystrom FH, Ravichandran LV, et al.: Roles for insulin receptor, PI3-kinase and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101: 1539–1545.

    PubMed  CAS  Google Scholar 

  73. Jiang ZY, Lin Y-W, Clemont A, et al.: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999, 104:447–457. A fascinating study, which for the first time documents that at least in obese rats, insulin-signaling pathways in blood vessels, which are considered antiatherogenic, such a the PI3-kinase pathway producing NO, are insulin resistant, whereas insulin stimulation of the mitogenactivated kinase pathway, which mediates cellular growth, is intact.

    PubMed  CAS  Google Scholar 

  74. McFarlane R, McCredie RJ, Bonney MA, et al.: Angiotensin converting enzyme inhibition and arterial endothelial function in adults with type 1 diabetes mellitus. Diabet Med 1999, 16:62–66.

    Article  PubMed  CAS  Google Scholar 

  75. Mullen MJ, Wright D, Donald A, et al.: Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol 2000, 36:410–416.

    Article  PubMed  CAS  Google Scholar 

  76. Bijlstra PJ, Smits P, Lutterman JA, Thien TH: Effect of long-term angiotensin-converting enzyme inhibition on endothelial function in patients with the insulin-resistance syndrome. J Cardiovasc Pharmacol 1995, 25:658–664.

    Article  PubMed  CAS  Google Scholar 

  77. O’Driscoll G, Green D, Maiorana A, et al.: Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1999, 33:1506–1511.

    Article  PubMed  CAS  Google Scholar 

  78. Keidar S, Kaplan M, Hoffman A, Aviram M: Angiotensin II stimulates macrophage-mediated oxidation of low-density lipoproteins. Atherosclerosis 1995, 115:201–215.

    Article  PubMed  CAS  Google Scholar 

  79. Evans M, Anderson RA, Graham J, et al.: Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation 2000, 101: 1773–1779.

    PubMed  CAS  Google Scholar 

  80. Cheetham C, O’Driscoll G, Stanton K, et al.: Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in type II diabetes. Clin Sci 2001, 100:13–17.

    Article  PubMed  CAS  Google Scholar 

  81. Rajagopalan S, Kruz S, Münzel T, et al.: Angiotensin II-mediated hypertension in the rat increases vascular super-oxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996, 97:1916–1923.

    Article  PubMed  CAS  Google Scholar 

  82. Cheetham C, Collis J, O’Driscoll G, et al.: Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 2000, 36:1461–1466.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Diabetes, University of Helsinki, P.O. Box 340, 00029, Helsinki, HUCH, Finland

    Sari Mäkimattila MD

Authors
  1. Sari Mäkimattila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hannele Yki-Järvinen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mäkimattila, S., Yki-Järvinen, H. Endothelial dysfunction in human diabetes. Curr Diab Rep 2, 26–36 (2002). https://doi.org/10.1007/s11892-002-0054-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-002-0054-x

Keywords

Search

Navigation